Day One Biopharmaceuticals (DAWN) Stock Chart & Stock Price History $6.21 +0.07 (+1.14%) Closing price 04:00 PM EasternExtended Trading$6.33 +0.12 (+1.92%) As of 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Day One Biopharmaceuticals Stock Price Performance The Day One Biopharmaceuticals (DAWN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 53.69%, with a year-to-date return of -50.99%. In the past month, the stock has decreased 8.54%, reflecting recent market activity. As of the latest close, Day One Biopharmaceuticals traded at $6.14 with a market cap of $628.92 million and volume of 2.59 million shares. Receive DAWN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.80%1 Month Performance-8.54%3 Month Performance-1.90%Year-To-Date Performance-50.99%1 Year Performance-53.69% DAWN Stock Chart for Wednesday, August, 13, 2025 DAWN Chart by TradingView Day One Biopharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/12/2025$5.90$6.14+4.07%$6.19$5.952.59 million shs$628.92 million08/11/2025$6.10$5.90-3.28%$6.25$5.901.74 million shs$604.35 million08/08/2025$6.03$6.10+1.16%$6.12$5.852.12 million shs$618.31 million08/07/2025$5.80$6.03+3.97%$6.08$5.832.31 million shs$611.20 million08/06/2025$6.88$5.80-15.70%$6.10$5.649.26 million shs$587.89 million08/05/2025$6.74$6.88+2.08%$7.04$6.674.39 million shs$697.36 million08/04/2025$6.65$6.74+1.35%$6.84$6.472.22 million shs$683.18 million08/01/2025$6.71$6.65-0.89%$6.72$6.431.05 million shs$674.06 million07/31/2025$6.87$6.71-2.33%$6.87$6.601.12 million shs$680.13 million07/30/2025$6.99$6.87-1.72%$7.18$6.841.02 million shs$696.34 million Get the Latest News and Ratings for DAWN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/29/2025$7.10$6.99-1.55%$7.12$6.931.52 million shs$708.52 million07/28/2025$7.23$7.10-1.80%$7.40$7.101.58 million shs$719.66 million07/25/2025$7.21$7.23+0.28%$7.34$7.071.50 million shs$732.83 million07/24/2025$6.94$7.21+3.89%$7.33$6.931.87 million shs$730.81 million07/23/2025$6.57$6.94+5.63%$6.99$6.581.53 million shs$703.45 million07/22/2025$6.40$6.57+2.66%$6.64$6.42894,498 shs$665.94 million07/21/2025$6.40$6.40$6.57$6.381.04 million shs$648.70 million07/18/2025$6.50$6.40-1.54%$6.62$6.321.87 million shs$648.70 million07/17/2025$6.62$6.50-1.81%$6.71$6.481.60 million shs$658.85 million07/16/2025$6.57$6.62+0.76%$6.73$6.521.55 million shs$671.00 million07/15/2025$6.93$6.57-5.19%$7.00$6.571.69 million shs$665.95 million07/14/2025$6.79$6.93+2.06%$7.00$6.69946,138 shs$702.44 million Related Companies Catalyst Pharmaceuticals Stock Chart Organon & Co. Stock Chart Kiniksa Pharmaceuticals International Stock Chart ImmunityBio Stock Chart Centessa Pharmaceuticals Stock Chart Arrowhead Pharmaceuticals Stock Chart Belite Bio Stock Chart Recursion Pharmaceuticals Stock Chart Bausch Health Cos Stock Chart Ocular Therapeutix Stock Chart Receive DAWN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DAWN) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Day One Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Day One Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access